Search Results 281-290 of 57096 for Compliance

  1. Extracorporeal membrane oxygenation (ECMO) - Mayo Clinic

    In extracorporeal membrane oxygenation (ECMO), blood is pumped outside of the body to a heart-lung machine. The machine removes carbon dioxide and sends oxygen- ...

  2. A Study Investigating the Safety, Tolerability, Pharmacokinetics, and Effectiveness of Mosunetuzumab (BTCT4465A) in Combination With CHOP or CHP-Polatuzumab Vedotin in Participants With B-Cell Non-Hodgkin Lymphoma - Mayo Clinic

    History of other malignancy that could affect compliance with the protocol or interpretation of results. Patients with a history of curatively treated basal ...

  3. Biomedical Ethics Research Program - Overview

    The Biomedical Ethics Research Program at Mayo Clinic conducts research and offers education and training about ethical questions in medicine and biomedical ...

  4. Timothy S. Larson, M.D. - Doctors and Medical Staff - Mayo Clinic

    ... Compliance Oversight Group, Health Information Coordinating Subcommittee - Rochester. 2007 - 2010. MemberExecutive Group, Information Technology Committee ...

  5. Hydrocortisone and acetic acid (otic route) - Side effects & dosage - Mayo Clinic

    Corticosteroid and acetic acid combinations are used to treat certain problems of the ear canal. They also help relieve the redness, itching, and swelling that ...

  6. Josh M. Hauser, M.D., M.P.H. - Doctors and Medical Staff - Mayo Clinic

    2022 - present. CV Division Safety LeadQuality and Compliance, Department of Anesthesiology and Perioperative Medicine. 2022 - present. MemberEvaluation ...

  7. PRE-I-SPY Phase I/Ib Oncology Platform Program - Mayo Clinic

    would limit compliance with study requirements). - GEC5: Cardiovascular disease: History (within 6 months prior to start IMP) of clinically significant ...

  8. A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Depemokimab in Adults With Hypereosinophilic Syndrome (HES) - Mayo Clinic

    The Investigator should evaluate the potential for contraceptive method failure (e.g., non-compliance, recently initiated) in relationship to the first dose of ...

  9. A Study to Examine the Long-Term Safety, Tolerability and Effectiveness of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients with Parkinson's Disease - Mayo Clinic

    ... compliance difficult; History of clinically significant hallucinations during the past 6 months; History of clinically significant impulse control disorder(s) ...

  10. A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell Carcinoma

    ... compliance and/or interpretation of treatment safety or effectiveness. High probability of protocol non-compliance (in opinion of investigator). Volunteers ...